Demographics (3)
- age - Subject age (phv00221155.v1.p1)
- sex - Gender of participant (phv00221156.v1.p1)
- SEX - Sex (phv00221148.v1.p1)
Disease Events (4)
- AFFECTION_STATUS - Case - control status of the subject (phv00221143.v1.p1)
- Autoimmunity - Diagnosis criteria - Autoimmunity (phv00221158.v1.p1)
- Developmental delay - Diagnosis criteria - Developmental delay (phv00221159.v1.p1)
- Immunodeficiency - Diagnosis criteria - Immunodeficiency (phv00221157.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte Type (phv00221162.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00221161.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00221142.v1.p1)
- FAMILY_ID - Family ID (phv00221144.v1.p1)
- FATHER - Father's Subject ID (phv00221147.v1.p1)
- GENOTYPING_CENTER - Genotyping Center (phv00221164.v1.p1)
- IS_TUMOR - Tumor status (phv00221163.v1.p1)
- MOTHER - Mother's Subject ID (phv00221146.v1.p1)
- SAMPLE_ID - Sample ID (phv00221150.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00221160.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00221151.v1.p1)
- SAMPLE_USE - Sample Use (phv00221153.v1.p1)
- SOURCE_SAMPLE_ID - Sample Source ID (phv00221152.v1.p1)
- SUBJECT_ID - Unique Subject ID (phv00221145.v1.p1)
- SUBJECT_ID - Subject ID (phv00221149.v1.p1)
- SUBJECT_ID - Subject ID (phv00221141.v1.p1)
- SUBJID - De-identified Subject ID (phv00221154.v1.p1)